WINNIPEG, MB / ACCESS Newswire / June 17, 2025 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that further to its news release on April 11, 2025, through its wholly-owned U.S. subsidiary Medicure Pharma Inc., it has... Read More

WINNIPEG, MB / ACCESS Newswire / May 21, 2025 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC Pink:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended March 31, 2025. The Company is also pleased to announce the voting results for... Read More

WINNIPEG, MB / ACCESS Newswire / April 25, 2025 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter and year ended December 31, 2024. Quarter and Year Ended December 31, 2024... Read More

WINNIPEG, MB / ACCESS Newswire / April 22, 2025 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the 2024 Year End Financial Results via conference call on April 29, 2025 at 8:30 am Eastern Time. The 2024 Year End Financials... Read More

WINNIPEG, MB / ACCESS Newswire / April 11, 2025 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that through its wholly-owned U.S. subsidiary, Medicure Pharma Inc., it has signed a definitive agreement on April 10, 2025... Read More

WINNIPEG, MB / ACCESS Newswire / March 11, 2025 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that further to its news release on February 18, 2025, through its wholly-owned U.S. subsidiary Medicure Pharma Inc., it has... Read More

WINNIPEG, MB / ACCESS Newswire / February 18, 2025 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that through its wholly-owned U.S. subsidiary, Medicure Pharma Inc., it has signed a definitive agreement on February 14, 2025... Read More

WINNIPEG, MB / ACCESSWIRE / November 25, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended September 30, 2024. Quarter Ended September 30, 2024 Highlights: Recorded... Read More

WINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the 2024 Q3 Financial Results on a Conference Call on November 26, 2024 at 8:30 am Eastern Time. The Q3 Financials will be filed... Read More

WINNIPEG, MB / ACCESSWIRE / October 24, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, announced today that a product development and supply contract settlement between its subsidiaries Medicure International Inc. & Medicure Pharma... Read More

WINNIPEG, MB / ACCESSWIRE / August 14, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, is pleased to announce that, further to its news release on June 24, 2024, it has acquired certain intellectual property assets of CanAm... Read More

WINNIPEG, ON / ACCESSWIRE / August 14, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended June 30, 2024. Quarter Ended June 30, 2024 Highlights: Recorded total net... Read More

WINNIPEG, MB / ACCESSWIRE / June 24, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announces it has signed an asset purchase agreement (" Agreement ") with CanAm Bioresearch Inc. (" CanAm ") for the acquisition of the patent... Read More

WINNIPEG, MB / ACCESSWIRE / May 28, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended March 31, 2024. The Company is also pleased to announce the voting results for the... Read More

WINNIPEG, MB / ACCESSWIRE / April 23, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, announced today that through its subsidiary, Medicure International Inc., the U.S. Food and Drug Administration (FDA) has granted Fast Track... Read More

WINNIPEG, MB / ACCESSWIRE / April 8, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTCPINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter and year ended December 31, 2023. Quarter and Year Ended December 31, 2023 Highlights:... Read More

WINNIPEG, MB / ACCESSWIRE / April 4, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the 2023 Year End Financial Results on a Conference Call on April 9, 2024 at 8:30 am Eastern Time. The 2023 Year End Financials will... Read More

WINNIPEG, MB / ACCESSWIRE / December 5, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, through its pharmacy subsidiary Marley Drug ® , a trusted national pharmacy known for its commitment to affordable healthcare solutions, is pleased... Read More

WINNIPEG, MB / ACCESSWIRE / November 23, 2023 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that the FDA provides complete approval to enroll patients in its pivotal Phase 3 clinical trial to evaluate the use of its... Read More

WINNIPEG, MB / ACCESSWIRE / November 21, 2023 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended September 30, 2023. Quarter Ended September 30, 2023 Highlights: Recorded... Read More

WINNIPEG, MB / ACCESSWIRE / August 29, 2023 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, reaffirms its commitment to providing affordable and straightforward access to its branded pitavastatin, ZYPITAMAG®, to people living with HIV through... Read More

WINNIPEG, MB / ACCESSWIRE / July 28, 2023 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended June 30, 2023. Quarter Ended June 30, 2023 Highlights: Recorded total net revenue... Read More

WINNIPEG, MB / ACCESSWIRE / July 24, 2023 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the 2023 Q2 Financial Results on a Conference Call on July 31, 2023 at 8:30 am Eastern Time. The Q2 Financials will be filed after... Read More

WINNIPEG, MB / ACCESSWIRE / May 26, 2023 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended March 31, 2023. Quarter Ended March 31, 2023 Highlights: Recorded total net revenue... Read More

WINNIPEG, MB / ACCESSWIRE / April 6, 2023 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH) (OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter and year ended December 31, 2022. Quarter and Year Ended December 31, 2022 Highlights:... Read More

WINNIPEG, MB / ACCESSWIRE / April 5, 2023 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the 2022 Year End Financial Results on a Conference Call on April 10, 2023 at 8:30 am Eastern Time. The 2022 Year End Financials will... Read More